CH CRL (R4)
0.9.0 - Draft
CH CRL (R4)
0.9.0 - Draft
This page is part of the CH CRL (R4) (v0.9.0: STU Draft) based on FHIR R4. . For a full list of available versions, see the Directory of published versions 
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="nkrs-irssstaging"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This code system http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-irssstaging defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style="white-space:nowrap">0<a name="nkrs-irssstaging-0"> </a></td><td>Stage 0</td><td>Patients treated conservatively. The tumour is confined to the globe. Enucleation has not been performed.</td></tr><tr><td style="white-space:nowrap">pI<a name="nkrs-irssstaging-pI"> </a></td><td>pStage I</td><td>Eye enucleated, completely resected histologically</td></tr><tr><td style="white-space:nowrap">pII<a name="nkrs-irssstaging-pII"> </a></td><td>pStage II</td><td>Eye enucleated, microscopic residual tumour</td></tr><tr><td style="white-space:nowrap">pIIIa<a name="nkrs-irssstaging-pIIIa"> </a></td><td>pStage IIIa</td><td>Regional extension: overt orbital disease</td></tr><tr><td style="white-space:nowrap">pIIIb<a name="nkrs-irssstaging-pIIIb"> </a></td><td>pStage IIIb</td><td>Regional extension: preauricular or cervical lymph node extension</td></tr><tr><td style="white-space:nowrap">cIVa.1<a name="nkrs-irssstaging-cIVa.461"> </a></td><td>cStage IVa.1</td><td>Haematogenous metastasis (without CNS involvement): single lesion</td></tr><tr><td style="white-space:nowrap">cIVa.2<a name="nkrs-irssstaging-cIVa.462"> </a></td><td>cStage IVa.2</td><td>Haematogenous metastasis (without CNS involvement): multiple lesions</td></tr><tr><td style="white-space:nowrap">cIVb.1<a name="nkrs-irssstaging-cIVb.461"> </a></td><td>cStage IVb.1</td><td>CNS extension (with or without any other site of regional or metastatic disease: prechiasmatic lesion</td></tr><tr><td style="white-space:nowrap">cIVb.2<a name="nkrs-irssstaging-cIVb.462"> </a></td><td>cStage IVb.2</td><td>CNS extension (with or without any other site of regional or metastatic disease: CNS mass</td></tr><tr><td style="white-space:nowrap">cIVb.3<a name="nkrs-irssstaging-cIVb.463"> </a></td><td>cStage IVb.3</td><td>CNS extension (with or without any other site of regional or metastatic disease: leptomeningeal and cerebrospinal fluid disease</td></tr></table></div>
</text>
<url value="http://fhir.ch/ig/ch-crl/CodeSystem/nkrs-irssstaging"/>
<version value="0.9.0"/>
<name value="NkrsIRSSStaging"/>
<title value="NKRS - IRSS Staging"/>
<status value="active"/>
<date value="2022-02-04T14:14:21+01:00"/>
<publisher value="Bundesamt für Gesundheit BAG"/>
<contact>
<name value="Bundesamt für Gesundheit BAG"/>
<telecom>
<system value="url"/>
<value value="https://www.bag.admin.ch/"/>
</telecom>
</contact>
<description
value="The paediatric International Retinoblastoma Staging System is based on extent
of disease and the presence of overt extra-ocular extension after enucleation.
**IRSS staging (Variable number: 4.23)**
in \'NATIONAL CANCER DATA DICTIONARY, V 1.1, Part A, BASIC VARIABLES for Adults, Adolescents, and Children (23.12.2019)\'
([EN](https://www.nacr.ch/assets/files/uploads/a-datadictionary-basicvariables-v1.1.pdf),
[DE](https://www.nkrs.ch/assets/files/uploads/a-datenstruktur-variablen-der-basisdaten-v1.1.pdf),
[FR](https://www.onec.ch/assets/files/uploads/a-dict-des-donnees-variables-de-base-v1.1.pdf),
[IT](https://www.snrt.ch/assets/files/uploads/a-dati-oncologici-variabili-di-base-v1.1.pdf))"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
</coding>
</jurisdiction>
<copyright value="CC-BY-SA-4.0"/>
<caseSensitive value="true"/>
<valueSet value="http://fhir.ch/ig/ch-crl/ValueSet/nkrs-irssstaging"/>
<content value="complete"/>
<count value="10"/>
<concept>
<code value="0"/>
<display value="Stage 0"/>
<definition
value="Patients treated conservatively. The tumour is confined to the globe. Enucleation has not been performed."/>
</concept>
<concept>
<code value="pI"/>
<display value="pStage I"/>
<definition value="Eye enucleated, completely resected histologically"/>
</concept>
<concept>
<code value="pII"/>
<display value="pStage II"/>
<definition value="Eye enucleated, microscopic residual tumour"/>
</concept>
<concept>
<code value="pIIIa"/>
<display value="pStage IIIa"/>
<definition value="Regional extension: overt orbital disease"/>
</concept>
<concept>
<code value="pIIIb"/>
<display value="pStage IIIb"/>
<definition
value="Regional extension: preauricular or cervical lymph node extension"/>
</concept>
<concept>
<code value="cIVa.1"/>
<display value="cStage IVa.1"/>
<definition
value="Haematogenous metastasis (without CNS involvement): single lesion"/>
</concept>
<concept>
<code value="cIVa.2"/>
<display value="cStage IVa.2"/>
<definition
value="Haematogenous metastasis (without CNS involvement): multiple lesions"/>
</concept>
<concept>
<code value="cIVb.1"/>
<display value="cStage IVb.1"/>
<definition
value="CNS extension (with or without any other site of regional or metastatic disease: prechiasmatic lesion"/>
</concept>
<concept>
<code value="cIVb.2"/>
<display value="cStage IVb.2"/>
<definition
value="CNS extension (with or without any other site of regional or metastatic disease: CNS mass"/>
</concept>
<concept>
<code value="cIVb.3"/>
<display value="cStage IVb.3"/>
<definition
value="CNS extension (with or without any other site of regional or metastatic disease: leptomeningeal and cerebrospinal fluid disease"/>
</concept>
</CodeSystem>